ArticleBone marrow transplantation2026

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Jesús Duque-Afonso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.